In relief to lenders, RBI eases provisioning norms for infrastructure financing
The RBI, in its final guidelines, has mandated that banks set aside only 1% of standard asset provisioning for projects under construction. It has, however, retained the provisioning requirement for operational projects at 0.4%. The provisioning requirement for loans for under-construction commercial real estate will be slightly higher at 1.25%.
The new norms come into effect from October.
Also read: Retail investors want a piece of NSE. But no one is selling
This is a major relaxation from the draft guidelines released in May last year that had proposed that lenders must set aside 5% of the loan amount—for potential losses—for an under-construction project, 2.5% for those already operational and 1% once the project has adequate cash flow to repay obligations.
'Rationalization of standard asset provisioning requirement to 1% for projects under construction, which shall gradually increase for each quarter of DCCO (date of commencement of commercial operations) deferment," said RBI.
Separately, RBI has permitted deferment of date of commencement of commercial operations to up to three years for infrastructure projects and up to two years for non-infra projects.
This is a bit tougher from the draft norms, which allowed up to four years of extension of DCCO due to all types of risks including legal.
Also read: Affordable housing financiers become market darlings after RBI rate cut
'Final guidelines on project finance comes as a relief to the lenders, as for operational projects the extant requirement continues at 0.4%, which is lower than 1%/2.5% indicated in the earlier draft. For under-construction project finance, provisions are kept at 1% vis-a-vis 5% suggested in the draft. This is however higher than 0.4% applicable at present for banks," Karthik Srinivasan, group head, financial sector ratings, ICRA, said.
He sees limited impact on NBFCs as sufficient provisions are provided as per the expected credit loss assessment and provisioning at present is closer to the requirement as per the guidelines. 'Also, the provisions are applicable prospectively, from October 2025 and, thus overall impact for lenders shall be limited," he added.
The RBI, under governor Sanjay Malhotra, has been taking steps to stimulate credit demand. Since January, the central bank has reduced risk weights on bank loans to small borrowers and non-bank lenders, eased rules for small-ticket gold loans and relaxed rules around strict liquidity requirements for banks.
In its final guidelines, the RBI has retained the individual lender exposure at not less than 10% of the aggregate exposure for under-construction projects where the aggregate exposure of the lenders is up to ₹1,500 crore.
For projects where aggregate exposure of all lenders is more than ₹1,500 crore, the exposure floor for an individual lender shall be 5% or ₹150 crore, whichever is higher.
Also read: Alcohol's become much more expensive in Maharashtra—but will still find takers
The RBI has relaxed the conditions for disbursement of funds. As per the new norms, infrastructure projects under public-private partnership (PPP) model need to ensure only 50% of the land available before disbursement. For non-PPP and commercial real estate projects, this requirement has been pegged at 75%. Currently, National Highways Authority of India projects under the annuity model need to ensure 90% of the land is made available before disbursement.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
38 minutes ago
- Time of India
RBI advises banks to integrate DoT's financial fraud technology
The Reserve Bank of India has advised all banks to integrate the Financial Fraud Risk Indicator tool developed by the Department of Telecom to curb online fraudulent transactions, an official statement said on and financial institutions can use the Financial Fraud Risk Indicator (FRI) in real time, which classifies mobile numbers based on their association with medium, high or very high risk of financial fraud. The data is collected from various sources, including reporting on the Indian Cyber Crime Coordination Centre (I4C's) National Cybercrime Reporting Portal (NCRP), DoT's Chakshu platform, and Intelligence shared by banks and financial institutions. "The Department of Telecommunications (DoT) welcomes the Reserve Bank of India's (RBI) advisory issued on June 30, 2025, directing all scheduled commercial banks, small finance banks, payments banks, and co-operative banks to integrate the Financial Fraud Risk Indicator (FRI) developed by DoT into their systems," the statement said. Launched in May 2025 by DoT's Digital Intelligence Unit (DIU), the system's utility has already been demonstrated, with leading institutions like PhonePe, Punjab National Bank , HDFC Bank , ICICI Bank , Paytm , and India Post Payments Bank actively using the platform. "With UPI being the most preferred payment method across India, this intervention could save millions of citizens from falling prey to cyber fraud. The FRI allows for swift, targeted, and collaborative action against suspected fraud in both telecom and financial domains," the statement said. DoT called the RBI move a "watershed moment in the fight against cyber-enabled financial frauds" and a testament to the power of inter-agency collaboration in safeguarding citizens in India's growing digital economy. "It also underscores the strategic importance of automating data exchange between banks and DoT's DIP through API-based integration, enabling real-time responsiveness and continuous feedback to further refine the fraud risk models," the statement said.
Time of India
an hour ago
- Time of India
CDMO and Generics the next pharma growth pillars: Gurmeet Chadha
So, we are pretty constructive. More importantly, if you see the correlation of pharma with Nifty, on a short-term basis it is around 0.6, on a long-term basis it is less than 0.5. Gurmeet Chadha suggests that with corporate profitability nearing all-time highs and markets at 21 times forward earnings, investors should temper return expectations. He recommends a balanced portfolio with long-dated bonds and gold. Rural demand is showing signs of recovery, while the pharma sector, particularly CDMO and generics, presents opportunities with lower correlation to the Nifty. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads "People have got some bit of consolidation in last six-nine months. So, you have to readjust to the new normal. You cannot make 25% returns when you are at 21 times earnings. So, have a more balanced allocation in terms of your portfolio, include some long-dated bonds, add maybe a bit of a flavour of gold, and be a little modest in terms of expectations," says Gurmeet Chadha, Complete Circle couple of things you have to see. One, our corporate profitability to GDP is now nearing all-time high. We are at almost 4.7%. The last time this had touched 5% was 2007-08. So, corporate profitability despite earning growth being mediocre is now at about 4.7% to the GDP. So, if you see last quarter earnings also, broader market, this I am talking about Nifty 500 , so broader market was about 11% plus earning if this quarter we do slightly better, then markets could sustain these levels because you are at 21 times forward earnings, so the market is not cheap. So, the earnings are extremely important. Market is also a little bit nervous on the US trade deal and what happens before 9th of July, so that event should play out over the next few days, so that is something the market would look up to and then maybe some of the sectors which have been impacted by tariffs whether it is auto, whether it is textile, whether it is selectively pharma, and host of other sectors will take more direction most importantly, we are seeing a bit of pickup in the rural demand , that is evident in two-wheeler numbers, that is evident in farm equipment and tractor numbers, that is evident in commentary you listen to some of the fertiliser companies, that is one good part of it. And historically, whenever monsoons have been 5% or 6% above normal, agriculture GVA is around 6%. So, it is about 2% higher than the long-term average which is 4%, which is a good sign, because we had a very soft rural economy for almost couple of now, the rural economy is coming back. Urban is still soft, probably needs a little more boost other than the rate cuts by RBI and maybe some GST cuts would the second half of the year could be better, but provided as I said, earnings play out and we do not have tariff issues. Secondly, most importantly, we have to reset our return expectations and we have been saying this for a while, we will not get 25-30% returns people have got some bit of consolidation in last six-nine months. So, you have to readjust to the new normal. You cannot make 25% returns when you are at 21 times earnings. So, have a more balanced allocation in terms of your portfolio, include some long-dated bonds, add maybe a bit of a flavour of gold, and be a little modest in terms of you break pharma into four subsets, the healthcare hospital part has done pretty well, whether it is Apollo, Max. Narayana also caught up pretty well. What I think could do well once there is more clarity is, the CDMO and generics, the market needs clarity in general is a huge opportunity. Already if you see the likes of Divi's, Laurus, some of the other names, they are already at their all-time high. And if you see the export numbers of last year versus now, 70% numbers have already happened in the first five-six there is more opportunity and once the Biosecure Act if at all finds light at the end of the tunnel in US, you could see Indian companies really gaining some market share vis-à-vis China. The last one is the branded generics bit, which is more like FMCG in Indian context, where valuations are slightly rich but you get steady, not much cyclicality in the we like Mankind in this space. We are tracking the likes of Ipca, Cipla , etc, in this we are pretty constructive. More importantly, if you see the correlation of pharma with Nifty, on a short-term basis it is around 0.6, on a long-term basis it is less than when corrections happen and in a market like this you got to also see downside risk in the sector, Nifty Pharma falls less than 50%. So, for example, if you go back to 2008 when markets fell 60%, Nifty Pharma was down 27%. In covid, again it fell half, in fact it recovered the fastest post.2011 again, it fell 15% versus 20-25% broader fall in the market. So, it is very important for us to look at risk adjusted returns and low correlation also while building a portfolio and pharma has outperformed Nifty over last 10, 15, 20 years. So, it falls lesser and over a long period outperforms, so deserves more allocation and more weight in the portfolio.
Mint
an hour ago
- Mint
Motilal Oswal AMC crosses ₹1.5 lakh crore AUM milestone; stock gains over 2%
Shares of Motilal Oswal Financial Services climbed over 2 percent in intra-day trade on Thursday, July 3, after the company announced that its asset management arm, Motilal Oswal Asset Management Company (MOAMC), had surpassed ₹ 1.5 lakh crore in assets under management (AUM) across mutual funds, PMS, and AIFs. According to the company, MOAMC's AUM has grown at a compound annual growth rate (CAGR) of 34 percent over the past five years, surging from ₹ 35,180 crore in June 2020 to over ₹ 1.5 lakh crore today. Motilal Oswal AMC's AUM is spread across ₹ 84,300 crore in active mutual funds, ₹ 33,600 crore in passive funds, ₹ 15,000 crore under portfolio management services (PMS), and ₹ 17,100 crore in Category-III Alternative Investment Funds (AIFs). The asset manager currently oversees close to 95 lakh unique folios and caters to around 79 lakh customers across more than 200 locations nationwide. This multi-platform scale demonstrates MOAMC's reach and growing trust among retail and institutional investors alike. In terms of mutual fund inflows, FY25 has marked a significant shift. MOAMC captured 7.8 percent of net sales in growth and equity-oriented mutual fund schemes, a notable rise from 1.9 percent in FY24. The total net flows for FY25 stood at ₹ 48,450 crore, with Systematic Investment Plans (SIPs) contributing ₹ 9,256 crore. The AMC attributes this growth to its earnings-focused investment philosophy and its emphasis on identifying quality, scalable businesses across emerging segments of the Indian market. Commenting on the achievement, Navin Agarwal, Group Managing Director of Motilal Oswal Financial Services Limited (MOFSL), said, 'Crossing ₹ 1.5 lakh crore in AUM is a significant milestone that reflects our commitment to equities and long-term investing. This underscores the strength of our philosophy—backing quality businesses with sustainable growth potential.' Prateek Agrawal, Managing Director & CEO of MOAMC, added, 'This milestone reflects our clients' conviction in our high-quality, high-growth investment approach and the relentless execution by our team. Our focus remains on building high-conviction portfolios differentiated from the index.' Following the announcement, shares of Motilal Oswal Financial Services rose as much as 2.1 percent to an intra-day high of ₹ 873.40 on the NSE. The stock remains 18 percent below its 52-week high of ₹ 1,063.40, which was hit in October 2024. It touched its 52-week low of ₹ 487.85 in April 2025. Despite recent volatility, the stock has gained 51 percent over the past year. It rose 7 percent in June, extending its monthly winning streak to four. Gains of 24 percent in May, 6 percent in April, and 4.5 percent in March preceded this rally. The stock had earlier dipped 7.6 percent in February and 33 percent in January.
